Vertex Pharmaceuticals (1VRTX) Ownership - Who Owns Vertex Pharmaceuticals?
Vertex Pharmaceuticals (1VRTX) Ownership Overview
- 0.22% Insiders
- 35.43% Mutual Funds
- 3.03% Other Institutional Investors
- 30.62% ETFs
- 30.70% Public Companies and Individual Investors
The ownership structure of Vertex Pharmaceuticals (IT:1VRTX) stock is a mix of institutional, retail, and individual investors. Approximately 69.08% of the company’s stock is owned by Institutional Investors, 0.22% is owned by Insiders, and 30.70% is owned by Public Companies and Individual Investors.
The ownership structure of Vertex Pharmaceuticals (IT:1VRTX) stock is a mix of institutional, retail, and individual investors. Approximately 69.08% of the company’s stock is owned by Institutional Investors, 0.22% is owned by Insiders, and 30.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Antipodes Partners Ltd | €57,576 | |
| Dec 31, 2025 | Gallacher Capital Management Llc | €374,928 | |
| Dec 31, 2025 | Entrypoint Capital, Llc | €483,281 | |
| Dec 31, 2025 | Graham Capital Management, L.p. | €540,858 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 20,841,516 | Institution | 8.22% | 11,716,871,039 |
| Vanguard Index Funds | 17,715,576 | Institution | 6.99% | 9,959,501,956 |
| Ishares | 16,559,054 | Institution | 6.53% | 9,309,318,009 |
| Growth Fund Of America | 12,908,237 | Institution | 5.09% | 7,256,868,851 |
| Spdr | 10,452,753 | Institution | 4.12% | 5,876,422,756 |
| Invesco | 9,717,892 | Institution | 3.83% | 5,463,291,986 |
| Investment Co Of America | 6,269,142 | Institution | 2.47% | 3,524,442,672 |
| American Balanced Fund | 5,558,357 | Institution | 2.19% | 3,124,847,163 |
| Amcap Fund | 4,734,921 | Institution | 1.87% | 2,661,920,502 |
| Fidelity Concord Street Trust | 4,575,593 | Institution | 1.81% | 2,572,348,053 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 17,715,576 | Institution | 6.99% | 9,959,501,956 |
| Growth Fund Of America | 12,908,237 | Institution | 5.09% | 7,256,868,851 |
| Investment Co Of America | 6,269,142 | Institution | 2.47% | 3,524,442,672 |
| American Balanced Fund | 5,558,357 | Institution | 2.19% | 3,124,847,163 |
| Amcap Fund | 4,734,921 | Institution | 1.87% | 2,661,920,502 |
| Fidelity Concord Street Trust | 4,575,593 | Institution | 1.81% | 2,572,348,053 |
| New Perspective Fund | 3,366,011 | Institution | 1.33% | 1,892,334,358 |
| Capital World Growth & Income Fund | 2,377,362 | Institution | 0.94% | 1,336,526,765 |
| Washington Mutual Investors Fund | 1,975,814 | Institution | 0.78% | 1,110,780,897 |
| Vanguard Specialized Funds | 1,890,142 | Institution | 0.75% | 1,062,617,041 |
FAQ
Who Owns Vertex Pharmaceuticals (IT:1VRTX)?
According to the latest TipRanks data, approximately 69.08% of the company's stock is held by institutional investors, 0.22% is held by insiders, and 30.70% is held by public companies and individual investors.
What percentage of Vertex Pharmaceuticals (IT:1VRTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 69.08% of Vertex Pharmaceuticals (IT:1VRTX) stock is held by institutional investors: 35.43% by mutual funds, 30.62% by ETFs and 3.03% by other institutional investors.
What percentage of Vertex Pharmaceuticals (IT:1VRTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.70% of Vertex Pharmaceuticals (IT:1VRTX) stock is held by public companies and individual investors.
Who owns the most shares of Vertex Pharmaceuticals (IT:1VRTX)?
Vanguard owns the most shares of Vertex Pharmaceuticals (IT:1VRTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.